Number of Shares] KEMPHARM, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 3rd, 2015 • Kempharm, Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 3rd, 2015 Company Industry Jurisdiction
AGREEMENT TO TERMINATE CLA BETWEEN MONOSOL RX, LLC AND KEMPHARM, INC. DATED AS OF MARCH 20, 2012Kempharm, Inc • April 3rd, 2015 • Pharmaceutical preparations
Company FiledApril 3rd, 2015 IndustryThis Agreement to Terminate CLA (“Agreement”), dated as of March 20, 2012 (the “Effective Date”), is between KemPharm, Inc., an Iowa corporation with its principal offices at 7 Hawkeye Drive, Suite 103, North Liberty, Iowa 52317 (“KemPharm”), and MonoSol Rx, LLC, a Delaware limited liability company with its principal offices at 30 Technology Drive, Warren, New Jersey, 07059 (“MSRx”).
ASSET PURCHASE AGREEMENT between SHIRE LLC and TRAVIS C. MICKLE, PH.D., AND KEMPHARM, INC. dated as of March 21, 2012Asset Purchase Agreement • April 3rd, 2015 • Kempharm, Inc • Pharmaceutical preparations • Delaware
Contract Type FiledApril 3rd, 2015 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is hereby entered into as of March 21, 2012 (the “Execution Date”) by and between, on the one hand, Shire LLC, a corporation organized and existing under the laws of Kentucky with its principal place of business in Florence, Kentucky (“Shire”), and, on the other hand, Travis C. Mickle, Ph.D. (“Travis Mickle”) and KemPharm, Inc., a corporation organized and existing under the laws of Iowa with its principal place of business in North Liberty, Iowa, and its Affiliates (as defined in Article 1) (“KemPharm,” and, collectively with Travis Mickle, the “KemPharm Parties”). Shire and the KemPharm Parties may each be referred to herein individually as a “Party,” and collectively as the “Parties.”
MATERIAL SUPPLY AGREEMENTMaterial Supply Agreement • April 3rd, 2015 • Kempharm, Inc • Pharmaceutical preparations • Iowa
Contract Type FiledApril 3rd, 2015 Company Industry JurisdictionThis Agreement is made and entered into and effective as of November 2, 2009 (the “Effective Date”) by and between Johnson Matthey Inc., a Pennsylvania corporation (“JMI”) and KemPharm, Inc., an Iowa corporation, with corporate headquarters located at 7 Hawkeye Drive Suite 103 North Liberty, IA 52317 (“Company”). This Agreement may be referenced in orders and other correspondence related hereto as Agreement No. 656